Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: a single center experience

BACKGROUND: Hurthle cell carcinoma makes up 3 to 5% of all thyroid cancers and is considered to be a true rarity. The aim of our study was to analyze clinical characteristics and survival rates of patients with Hurthle cell carcinoma. METHODS: Clinical data regarding basic demographic characteristic...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Oluic, Branisav, Paunovic, Ivan, Loncar, Zlatibor, Djukic, Vladimir, Diklic, Aleksandar, Jovanovic, Milan, Garabinovic, Zeljko, Slijepcevic, Nikola, Rovcanin, Branislav, Micic, Dusan, Filipovic, Aleksandar, Zivaljevic, Vladan
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5445517/
https://ncbi.nlm.nih.gov/pubmed/28545571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3370-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky